Major Hematological Response Is the Main Factor for Achieving a Major Molecular Response in JAK2V617F-Positive Essential Thrombocythemia and Polycythemia Vera Patients Treated with Hydroxyurea

被引：4
|
作者：
Besses, C. [1 ]
Alvarez-Larran, A. [1 ]
Martinez-Aviles, L. [1 ]
Longaron, R. [1 ]
Serrano, S. [1 ]
Bellosillo, B. [1 ]
机构：
[1] Hosp Mar, Barcelona, Spain
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
10.1182/blood.V112.11.660.660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [1] GENE EXPRESSION PROFILE IN JAK2 V617F POSITIVE POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA RELATED TO RESPONSE TO HYDROXYUREA TREATMENT
    Miguel, G.
    Santiago, S.
    Enriqueta, A.
    Inmaculada, I.
    Rosa, R.
    Jimenez, A.
    Daniel, D.
    Eulalia, E.
    Blanca, B.
    Lourdes, L.
    Carles, C.
    Joaquin, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 400 - 401
  • [2] Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera
    Mohamad Cherry
    Mohamad Khawandanah
    Zhizhuang Joe Zhao
    Samer Srour
    Howard Ozer
    George Selby
    Bassam Ghabache
    Aref Al-Kali
    Annals of Hematology, 2015, 94 : 717 - 719
  • [3] Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera
    Cherry, Mohamad
    Khawandanah, Mohamad
    Zhao, Zhizhuang Joe
    Srour, Samer
    Ozer, Howard
    Selby, George
    Ghabache, Bassam
    Al-Kali, Aref
    ANNALS OF HEMATOLOGY, 2015, 94 (04) : 717 - 719
  • [4] Association of the ACE I/D Gene Polymorphisms with JAK2V617F-Positive Polycythemia Vera and Essential Thrombocythemia
    Gorukmez, Orhan
    Sag, Sebnem Ozemri
    Gorukmez, Ozlem
    Ture, Mehmet
    Topak, Ali
    Sahinturk, Serdar
    Ozkaya, Guven
    Gulten, Tuna
    Ali, Ridvan
    Yakut, Tahsin
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2015, 19 (06) : 303 - 308
  • [5] Impact of JAK2V617F Mutation Burden on Disease Phenotype in Chinese Patients with JAK2V617F-positive Polycythemia Vera (PV) and Essential thrombocythemia (ET)
    Zhao, Shixiang
    Zhang, Xiang
    Xu, Yang
    Feng, Yufeng
    Sheng, Wenhong
    Cen, Jiannong
    Wu, Depei
    Han, Yue
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2016, 13 (01): : 85 - 91
  • [6] JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib
    Pieri, Lisa
    Pancrazzi, Alessandro
    Pacilli, Annalisa
    Rabuzzi, Claudia
    Rotunno, Giada
    Fanelli, Tiziana
    Guglielmelli, Paola
    Fjerza, Rajmonda
    Paoli, Chiara
    Verstovsek, Srdan
    Vannucchi, Alessandro M.
    BLOOD, 2015, 125 (21) : 3352 - 3353
  • [7] Chorea Associated with JAK2V617F-Positive Essential Thrombocythemia
    Calculli, Alessandra
    Arceri, Sebastiano
    Pisani, Antonio
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (01): : 154 - 155
  • [8] INFLUENCE OF ALLELIC LOAD OF JAK2V617F OF THE CD34+CELLS IN THE MOLECULAR RESPONSE TO THE TREATMENT WITH HYDROXYUREA IN PATIENTS WITH POLYCYTHEMIA VERA AND ESSENTIAL THROMBOCYTHEMIA
    Angona Figueras, A.
    Alvarez Larran, A.
    Bellosillo Paricio, B.
    Longaron Rozalen, R.
    Camacho Diaz, L.
    Fernandez Rodriguez, C.
    Pairet Garcia, S.
    Garcia Pallarols, F.
    Senin Megan, A.
    Johansson Barron, E.
    Torres Grande, E.
    Besses Raebel, C.
    HAEMATOLOGICA, 2015, 100 : 189 - 189
  • [9] Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia
    Richsten, Anne
    Palmqvist, Lars
    Johansson, Peter
    Andreasson, Bjoern
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (08): : 1260 - 1261
  • [10] Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia
    Ozlem Cırpan Ayvaz
    Irfan Yavasoglu
    Gurhan Kadikoylu
    Gokay Bozkurt
    Zahit Bolaman
    Rheumatology International, 2012, 32 : 269 - 271
12345